Same Indication

Ipilimumab vs Rabeprazole

Ipilimumab vs Rabeprazole: Overview

This comparison examines the pharmacological differences between Ipilimumab and Rabeprazole.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Rabeprazole — 1-2 hours.

Chemical Properties

Molecular Formula: Rabeprazole — C18H21N3O3S.

Molecular Weight: Rabeprazole — 359.4440 g/mol.

Type: Ipilimumab — Antibody; Rabeprazole — Small molecule.